Fortis Healthcare Limited

Financial Results Overview

Standalone Results (Rupees in lacs):

  • Total Income: ₹50,837 (Q1 FY27) vs ₹44,304 (Q1 FY26)
  • Total Expenses: ₹46,242 (Q1 FY27) vs ₹39,695 (Q1 FY26)
  • Profit Before Tax: ₹4,601 (Q1 FY27) vs ₹4,609 (Q1 FY26)
  • Exceptional Items: ₹1,330 gain (Q1 FY27) vs ₹1,688 gain (Q1 FY26)
  • Profit After Tax: ₹4,778 (Q1 FY27) vs ₹5,188 (Q1 FY26)
  • EPS: ₹0.63 (Q1 FY27) vs ₹0.69 (Q1 FY26)

Consolidated Results (Rupees in lacs):

  • Total Income: ₹254,503 (Q1 FY27) vs ₹218,212 (Q1 FY26)
  • Total Expenses: ₹221,023 (Q1 FY27) vs ₹184,710 (Q1 FY26)
  • Profit Before Tax: ₹36,318 (Q1 FY27) vs ₹35,057 (Q1 FY26)
  • Exceptional Items: ₹953 gain (Q1 FY27) vs ₹1,263 gain (Q1 FY26)
  • Profit After Tax: ₹27,280 (Q1 FY27) vs ₹26,678 (Q1 FY26)
  • EPS: ₹3.53 (Q1 FY27) vs ₹3.45 (Q1 FY26)

Key Financial Metrics

Standalone Ratios:

  • Debt to Equity: 0.20 (Q1 FY27)
  • Debt Service Coverage: 0.87 (Q1 FY27)
  • Interest Service Coverage: 2.62 (Q1 FY27)
  • Current Ratio: 0.41 (Q1 FY27)
  • Operating Profit Margin: 21.25% (Q1 FY27)
  • Net Profit Margin: 7.05% (Q1 FY27)

Consolidated Ratios:

  • Debt to Equity: 0.31 (Q1 FY27)
  • Debt Service Coverage: 1.06 (Q1 FY27)
  • Interest Service Coverage: 6.91 (Q1 FY27)
  • Current Ratio: 0.82 (Q1 FY27)
  • Operating Profit Margin: 21.29% (Q1 FY27)
  • Net Profit Margin: 10.35% (Q1 FY27)

Appointment of Tax Auditors

Re-appointed M/s. B S R & Co. LLP, Chartered Accountants (Registration No. 101248W/W-100022) as Tax Auditors for Financial Year 2025-26 effective August 06, 2026. The firm has over 4000 staff and 170+ Partners across 14 locations.

Regulatory and Legal Matters

SFIO Investigation: Ongoing investigation regarding alleged improper transactions and non-compliances with laws relating to period prior to March 2018. Company has provided information and cooperated with authorities. Provisions made in FY 2021 for potential contingencies.

SEBI Matters:

  • SCN-1: Penalty of ₹100 lacs on Company and ₹50 lacs on FHsL imposed April 2022. Appeals pending before Securities Appellate Tribunal with 50% penalty amount deposited under protest.
  • SCN-2: Penalty of ₹100 lacs on EHIRCL imposed May 2022. Appeal pending with SAT, 50% penalty deposited.

Supreme Court Matters:

  • Order dated September 22, 2022 directed Delhi High Court to consider appointing forensic auditors to analyze FHL-RHT transactions.
  • Mandatory open offer completed November 10, 2025 following resolution of status quo order.

Brand Acquisition:

  • Acquired 'Fortis' brand and allied trademarks for ₹20,000 lacs through court auction in December 2024.
  • Acquired 'SRL' brand for ₹800 lacs through court auction in June 2025.

Operational Highlights

Segment Performance (Consolidated):

  • Healthcare Revenue: ₹218,667 lacs (Q1 FY27)
  • Diagnostics Revenue: ₹40,654 lacs (Q1 FY27)
  • Healthcare Segment Profit: ₹34,701 lacs (Q1 FY27)
  • Diagnostics Segment Profit: ₹6,382 lacs (Q1 FY27)

Recent Acquisitions:

  • Acquired TMI Healthcare Private Limited (People Tree Hospital, Bengaluru) for ₹43,386 lacs in January 2026.
  • Transferred Richmond Road Hospital business to Vikram Aura Private Limited for ₹2,275 lacs in December 2024.

Corporate Actions

  • Granted 1,30,87,600 ESOPs under Fortis Healthcare Limited Employees Stock Option Scheme 2026.
  • Recommended final dividend of ₹1.00 per equity share (10% on face value) for FY 2025-26, subject to shareholder approval.

Debt Covenant Compliance

Certificate from B S R & Co. LLP confirms financial covenants under debenture trust deed not required to be tested as of June 30, 2026 (next testing due at fiscal year-end).

Board Meeting Details

Meeting commenced at 12:00 Noon IST and concluded at 6:45 PM IST on August 06, 2026.